NR566 MIDTERM EXAM /
APPROVED NR566 WEEK 4
ADVANCED PHARMACOLOGY
FOR CARE OF THE FAMILY
NR566 MIDTERM EXAM / APPROVED NR566 WEEK |
Comprehensive Examination
NR566 MIDTERM EXAM / APPROVED NR566 WEEK 4
ADVANCED PHARMACOLOGY FOR CARE OF THE
FAMILY EXAMPLIFY PROCTORED MIDTERM EXAM
INTRODUCTION
This document is an important and very helpful preparation
resource for NR566 MIDTERM EXAM / APPROVED NR566
WEEK 4 ADVANCED PHARMACOLOGY FOR CARE OF
THE FAMILY EXAMPLIFY PROCTORED MIDTERM
EXAM ACTUAL 2026/2027 COMPREHENSIVE TEST BANK
AND HIGH YIELD PRACTICE QUESTIONS ACCURATE
EXAM COMPLETE APPROVED QUESTIONS WITH WELL
ELABORA. Every item uses a focused exam stem, four
response options, a keyed response, and a clear rationale,
making it easier to understand the subject, spot distractors, and
build real exam confidence.
Page 1
, Question 1
A patient with heart failure with reduced ejection fraction (HFrEF) is initiated
on sacubitril/valsartan. Which instruction is essential regarding the prior ACE
inhibitor?
A. Continue the ACE inhibitor concurrently for additive benefit.
B. Discontinue the ACE inhibitor 36 hours before starting
sacubitril/valsartan.
C. Discontinue the ACE inhibitor 7 days before starting
sacubitril/valsartan.
D. No washout is required; the ACE inhibitor can be stopped the same
day.
Correct Answer: B - Discontinue the ACE inhibitor 36 hours
before starting sacubitril/valsartan.
RATIONALE
A 36-hour washout is required after stopping an ACE inhibitor before
initiating sacubitril/valsartan to avoid angioedema from dual
bradykinin potentiation. Concurrent use (A) is contraindicated, and 7
days (C) is unnecessarily long. Same-day transition (D) ignores the
pharmacodynamic interaction.
Question 2
A patient with major depressive disorder is a CYP2D6 poor metabolizer.
Which antidepressant is most appropriate to avoid significant accumulation?
A. Fluoxetine
B. Paroxetine
C. Sertraline
D. Venlafaxine
Correct Answer: C - Sertraline
Page 2
, RATIONALE
Sertraline is less dependent on CYP2D6 for clearance, making it safer
in poor metabolizers. Fluoxetine, paroxetine, and venlafaxine are all
significantly metabolized by CYP2D6 and may accumulate, increasing
adverse effects.
Question 3
A patient on warfarin is prescribed trimethoprim-sulfamethoxazole for a UTI.
Which monitoring plan is most appropriate?
A. No change; the interaction is not clinically significant.
B. Increase warfarin dose empirically and check INR in 1 week.
C. Check INR in 3-5 days and anticipate a possible warfarin dose
reduction.
D. Switch warfarin to a direct oral anticoagulant immediately.
Correct Answer: C - Check INR in 3-5 days and anticipate a
possible warfarin dose reduction.
RATIONALE
Trimethoprim-sulfamethoxazole inhibits CYP2C9 and can markedly
increase INR; close monitoring and possible warfarin reduction are
needed. Ignoring the interaction (A) risks bleeding, while empirical
increase (B) is dangerous. Immediate switching (D) is not always
necessary and may be inappropriate.
Question 4
A patient with type 2 diabetes and stage 3 chronic kidney disease has an
HbA1c of 8.2% on metformin. Which addition best aligns with current
cardiorenal guidelines?
A. Glyburide
B. Pioglitazone
C. Empagliflozin
D. Sitagliptin
Page 3
, Correct Answer: C - Empagliflozin
RATIONALE
SGLT2 inhibitors like empagliflozin provide cardiorenal protection
and are recommended in CKD. Glyburide risks hypoglycemia in
CKD, pioglitazone may worsen fluid retention, and sitagliptin lacks
the same renal benefit.
Question 5
A patient with asthma uses albuterol more than twice weekly. Which controller
is preferred for long-term management?
A. Montelukast
B. Low-dose inhaled corticosteroid
C. Long-acting beta-agonist monotherapy
D. Oral prednisone
Correct Answer: B - Low-dose inhaled corticosteroid
RATIONALE
Inhaled corticosteroids are the preferred controller for persistent
asthma. Montelukast is less effective, LABA monotherapy is
contraindicated due to risk of severe exacerbations, and oral
prednisone is reserved for exacerbations.
Question 6
A patient on levothyroxine reports fatigue. Labs show TSH elevated and free
T4 low. Which factor most likely explains this?
A. Taking levothyroxine with calcium carbonate
B. Taking levothyroxine on an empty stomach
C. Taking levothyroxine with water
D. Taking levothyroxine at bedtime
Correct Answer: A - Taking levothyroxine with calcium
carbonate
Page 4
APPROVED NR566 WEEK 4
ADVANCED PHARMACOLOGY
FOR CARE OF THE FAMILY
NR566 MIDTERM EXAM / APPROVED NR566 WEEK |
Comprehensive Examination
NR566 MIDTERM EXAM / APPROVED NR566 WEEK 4
ADVANCED PHARMACOLOGY FOR CARE OF THE
FAMILY EXAMPLIFY PROCTORED MIDTERM EXAM
INTRODUCTION
This document is an important and very helpful preparation
resource for NR566 MIDTERM EXAM / APPROVED NR566
WEEK 4 ADVANCED PHARMACOLOGY FOR CARE OF
THE FAMILY EXAMPLIFY PROCTORED MIDTERM
EXAM ACTUAL 2026/2027 COMPREHENSIVE TEST BANK
AND HIGH YIELD PRACTICE QUESTIONS ACCURATE
EXAM COMPLETE APPROVED QUESTIONS WITH WELL
ELABORA. Every item uses a focused exam stem, four
response options, a keyed response, and a clear rationale,
making it easier to understand the subject, spot distractors, and
build real exam confidence.
Page 1
, Question 1
A patient with heart failure with reduced ejection fraction (HFrEF) is initiated
on sacubitril/valsartan. Which instruction is essential regarding the prior ACE
inhibitor?
A. Continue the ACE inhibitor concurrently for additive benefit.
B. Discontinue the ACE inhibitor 36 hours before starting
sacubitril/valsartan.
C. Discontinue the ACE inhibitor 7 days before starting
sacubitril/valsartan.
D. No washout is required; the ACE inhibitor can be stopped the same
day.
Correct Answer: B - Discontinue the ACE inhibitor 36 hours
before starting sacubitril/valsartan.
RATIONALE
A 36-hour washout is required after stopping an ACE inhibitor before
initiating sacubitril/valsartan to avoid angioedema from dual
bradykinin potentiation. Concurrent use (A) is contraindicated, and 7
days (C) is unnecessarily long. Same-day transition (D) ignores the
pharmacodynamic interaction.
Question 2
A patient with major depressive disorder is a CYP2D6 poor metabolizer.
Which antidepressant is most appropriate to avoid significant accumulation?
A. Fluoxetine
B. Paroxetine
C. Sertraline
D. Venlafaxine
Correct Answer: C - Sertraline
Page 2
, RATIONALE
Sertraline is less dependent on CYP2D6 for clearance, making it safer
in poor metabolizers. Fluoxetine, paroxetine, and venlafaxine are all
significantly metabolized by CYP2D6 and may accumulate, increasing
adverse effects.
Question 3
A patient on warfarin is prescribed trimethoprim-sulfamethoxazole for a UTI.
Which monitoring plan is most appropriate?
A. No change; the interaction is not clinically significant.
B. Increase warfarin dose empirically and check INR in 1 week.
C. Check INR in 3-5 days and anticipate a possible warfarin dose
reduction.
D. Switch warfarin to a direct oral anticoagulant immediately.
Correct Answer: C - Check INR in 3-5 days and anticipate a
possible warfarin dose reduction.
RATIONALE
Trimethoprim-sulfamethoxazole inhibits CYP2C9 and can markedly
increase INR; close monitoring and possible warfarin reduction are
needed. Ignoring the interaction (A) risks bleeding, while empirical
increase (B) is dangerous. Immediate switching (D) is not always
necessary and may be inappropriate.
Question 4
A patient with type 2 diabetes and stage 3 chronic kidney disease has an
HbA1c of 8.2% on metformin. Which addition best aligns with current
cardiorenal guidelines?
A. Glyburide
B. Pioglitazone
C. Empagliflozin
D. Sitagliptin
Page 3
, Correct Answer: C - Empagliflozin
RATIONALE
SGLT2 inhibitors like empagliflozin provide cardiorenal protection
and are recommended in CKD. Glyburide risks hypoglycemia in
CKD, pioglitazone may worsen fluid retention, and sitagliptin lacks
the same renal benefit.
Question 5
A patient with asthma uses albuterol more than twice weekly. Which controller
is preferred for long-term management?
A. Montelukast
B. Low-dose inhaled corticosteroid
C. Long-acting beta-agonist monotherapy
D. Oral prednisone
Correct Answer: B - Low-dose inhaled corticosteroid
RATIONALE
Inhaled corticosteroids are the preferred controller for persistent
asthma. Montelukast is less effective, LABA monotherapy is
contraindicated due to risk of severe exacerbations, and oral
prednisone is reserved for exacerbations.
Question 6
A patient on levothyroxine reports fatigue. Labs show TSH elevated and free
T4 low. Which factor most likely explains this?
A. Taking levothyroxine with calcium carbonate
B. Taking levothyroxine on an empty stomach
C. Taking levothyroxine with water
D. Taking levothyroxine at bedtime
Correct Answer: A - Taking levothyroxine with calcium
carbonate
Page 4
